Results 1 to 10 of about 1,105,547 (207)
The burden of systemic sclerosis in Switzerland – the Swiss systemic sclerosis EUSTAR cohort [PDF]
Swiss Medical Weekly, 2021 OBJECTIVES Characteristics of Swiss patients with systemic sclerosis have not been described so far. The aim of the current study was to identify unmet needs in comparison with other European countries that could inform specific interventions
Jasmin Hernández +23 more
doaj +3 more sources
SYSTEMIC SCLEROSIS AND OSTEOPOROSIS
Alʹmanah Kliničeskoj Mediciny, 2016 Systemic sclerosis is an autoimmune inflammatory disease of connective tissue with multi-syndrome clinical manifestations. Skeletal damage is considered to be one of significant contributors to the quality of life of these patients.
R. T. Alekperov, N. V. Toroptsova
doaj +2 more sources
Systemic sclerosis – diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1: diagnosis and monitoring [PDF]
Przegląd Dermatologiczny, 2017 Systemic sclerosis is an immune-mediated disease characterized by a chronic and progressive course. It often leads to multiorgan failure and patient disability, and contributes to significant reduction in the quality of life.
Dorota Krasowska +10 more
doaj +2 more sources
Progressive systemic sclerosis in a child
Indian Journal of Dermatology, 2013 Systemic sclerosis is a clinically heterogeneous systemic disease affecting the connective tissues of skin, walls of blood vessels and internal organs like lung, heart and kidneys. Systemic sclerosis is very unusual in pediatric population.
Arun K De +3 more
doaj +2 more sources
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
Clinical Epidemiology, 2019 Aurore Bergamasco,1 Nadine Hartmann,2 Laura Wallace,3 Patrice Verpillat41YolaRx Consultants, Paris, France; 2Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; 3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CO, USA ...
Bergamasco A +3 more
doaj +1 more source
Biologics: Targets & Therapy, 2008 Mathieu C Tamby1, Amélie Servettaz1, Nicolas Tamas1, Joseph Reinbolt2, Frédéric Caux3, Olivier Meyer4, Yannick Allanore5, André Kahan5, Loïc Guillevin6, Luc Mouthon1,61Paris-Descartes University ...
Mathieu C Tamby +5 more
doaj +1 more source
Animal models of systemic sclerosis: their utility and limitations
Open Access Rheumatology: Research and Reviews, 2014 Carol M Artlett Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA Abstract: Without doubt, animal models have provided significant insights into our understanding of the rheumatological diseases ...
Artlett CM
doaj +1 more source
Diagnostics, 2023 Determination of salivary flow rate and oral status in patients with primary Sjögren’s Syndrome (pSS) and diffuse cutaneous systemic sclerosis (dcSSc) and comparison with control subjects.
Ana Glavina +6 more
doaj +1 more source
Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
Current Issues in Molecular Biology, 2023 Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad spectrum of clinical manifestations. The proposed pathophysiological hypotheses of SLE are numerous, involving both innate and adaptive abnormal immune responses.
Marin Petrić, Mislav Radić
doaj +1 more source
Exercise and physical therapy for systemic sclerosis [PDF]
, 2022 Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:.
Espinosa-Cuervo, Gisela +4 more
core +1 more source